Jasper Therapeutics (JSPR) Institutional Ownership $2.86 -0.04 (-1.52%) As of 02:18 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Jasper Therapeutics (NASDAQ:JSPR)CurrentInstitutional OwnershipPercentage79.85%Number ofInstitutional Buyers(last 12 months)42TotalInstitutional Inflows(last 12 months)$56.35MNumber ofInstitutional Sellers(last 12 months)14TotalInstitutional Outflows(last 12 months)$18.54M Get JSPR Insider Trade Alerts Want to know when executives and insiders are buying or selling Jasper Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Chart & View Institutional Buying and Selling Data JSPR Institutional Buying and Selling by Quarter Jasper Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails8/19/2025 Marex Group plc13,300$74K0.0%N/A0.089% 8/15/2025 Engineers Gate Manager LP13,972$78K0.0%N/A0.093% 8/15/2025 Bank of America Corp DE293,460$1.63M0.0%-18.6%1.954% 8/14/2025 Jane Street Group LLC132,905$738K0.0%N/A0.885% 8/13/2025 Marshall Wace LLP50,686$281K0.0%N/A0.337% 8/12/2025 XTX Topco Ltd27,348$152K0.0%N/A0.182% 8/12/2025 JPMorgan Chase & Co.65,088$361K0.0%+1,074.7%0.433% 8/8/2025 Geode Capital Management LLC131,130$728K0.0%-50.3%0.873% 8/5/2025 Corton Capital Inc.10,004$56K0.1%-62.1%0.067% 8/5/2025 Bank of Montreal Can158,133$878K0.0%+120.4%1.053% Get the Latest News and Ratings for JSPR and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Jasper Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 7/14/2025 Sowell Financial Services LLC17,303$96K0.0%-16.9%0.115% 6/27/2025 Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556% 5/21/2025 Acadian Asset Management LLC10,708$46K0.0%N/A0.071% 5/16/2025 Goldman Sachs Group Inc.233,758$1.01M0.0%+11.2%1.556% 5/15/2025 Kingdon Capital Management L.L.C.490,000$2.11M0.2%+9.6%3.262% 5/14/2025 T. Rowe Price Investment Management Inc.702,757$3.02M0.0%+755.3%4.678% 5/12/2025 Nuveen LLC102,268$440K0.0%N/A0.681% 5/9/2025 Charles Schwab Investment Management Inc.26,648$115K0.0%-17.6%0.177% 5/7/2025 Corton Capital Inc.26,382$113K0.4%N/A0.176% 4/17/2025 Sowell Financial Services LLC20,825$90K0.0%-25.7%0.139% 3/24/2025 Wellington Management Group LLP27,069$579K0.0%+13.9%0.180% 2/27/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208% 2/17/2025 Woodline Partners LP245,676$5.25M0.0%-50.4%1.638% 2/17/2025 Soleus Capital Management L.P.1,494,420$31.95M2.0%+11.2%9.962% 2/17/2025 Tema Etfs LLC12,435$266K0.1%N/A0.083% 2/17/2025 Stempoint Capital LP135,244$2.89M0.7%N/A0.902% 2/17/2025 Integral Health Asset Management LLC650,000$13.90M1.2%+85.7%4.333% 2/17/2025Jefferies Financial Group Inc.31,250$668K0.0%N/A0.208% 2/17/2025 Deutsche Bank AG170,695$3.65M0.0%+30.0%1.138% 2/17/2025 Braidwell LP714,658$15.28M0.5%+47.9%4.764% 2/17/2025 Bank of America Corp DE287,204$6.14M0.0%-11.9%1.915% 2/17/2025 Allostery Investments LP22,000$470K0.5%N/A0.147% 2/17/2025 Ally Bridge Group NY LLC122,424$2.62M2.2%-69.4%0.816% 2/14/2025 Boxer Capital Management LLC350,000$7.48M0.6%N/A2.333% 2/14/2025 Jane Street Group LLC10,852$232K0.0%-18.7%0.072% 2/14/2025 Northern Trust Corp104,367$2.23M0.0%-2.4%0.696% 2/14/2025 Propel Bio Management LLC20,000$428K0.4%N/A0.133% 2/14/2025 T. Rowe Price Investment Management Inc.82,165$1.76M0.0%N/A0.548% 2/14/2025 Rock Springs Capital Management LP463,088$9.90M0.4%+0.9%3.087% 2/13/2025 Marshall Wace LLP77,722$1.66M0.0%+17.2%0.518% Elon’s BIGGEST warning yet? (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough.Click here to see why Tesla's about to prove everyone wrong... again.2/13/2025 Mariner LLC36,794$787K0.0%-12.8%0.245% 2/13/2025 Barclays PLC18,334$392K0.0%+13.6%0.122% 2/13/2025 Russell Investments Group Ltd.247,272$5.29M0.0%+16.9%1.648% 2/13/2025 Wells Fargo & Company MN7,415$159K0.0%+106.7%0.049% 2/12/2025 Wellington Management Group LLP27,069$579K0.0%+13.9%0.180% 2/12/2025 Schroder Investment Management Group59,034$1.24M0.0%N/A0.394% 2/12/2025 JPMorgan Chase & Co.5,165$110K0.0%-68.5%0.034% 2/11/2025 EntryPoint Capital LLC10,431$223K0.1%N/A0.070% 2/11/2025 Simplify Asset Management Inc.20,000$428K0.0%N/A0.133% 1/30/2025 Rhumbline Advisers14,761$316K0.0%+12.6%0.098% 12/26/2024 JPMorgan Chase & Co.16,391$308K0.0%+239.8%0.109% 11/27/2024 Franklin Resources Inc.579,636$10.90M0.0%-17.0%3.864% 11/19/2024 Barclays PLC16,146$304K0.0%+320.7%0.108% 11/16/2024 Geode Capital Management LLC257,416$4.84M0.0%-0.9%1.704% 11/15/2024 Barclays PLC16,146$304K0.0%+320.7%0.107% 11/15/2024 Jane Street Group LLC13,354$251K0.0%N/A0.088% 11/15/2024 Wellington Management Group LLP23,759$447K0.0%N/A0.157% 11/15/2024 State Street Corp214,883$4.04M0.0%+12.3%1.423% 11/15/2024 Samsara BioCapital LLC584,642$11.00M2.1%+11.4%3.872% 11/15/2024 Ikarian Capital LLC55,175$1.04M0.1%-47.5%0.365% 11/14/2024 Braidwell LP483,300$9.09M0.3%N/A3.201% 11/14/2024 Verition Fund Management LLC25,353$477K0.0%N/A0.168% 11/14/2024 Ally Bridge Group NY LLC399,466$7.51M4.0%+82.7%2.645% 11/14/2024 MetLife Investment Management LLC6,874$129K0.0%+129.1%0.046% 11/13/2024 Great Point Partners LLC322,380$6.06M1.8%-19.8%2.135% 11/13/2024 BNP Paribas Financial Markets2,512$47K0.0%+208.6%0.017% 11/13/2024 FMR LLC38,361$722K0.0%N/A0.254% 10/30/2024AlphaCentric Advisors LLC17,500$329K0.2%N/A0.116% 10/29/2024Fernwood Investment Management LLC52,897$995K0.3%+6.9%0.351% 10/16/2024 Wolff Wiese Magana LLC3,146$59K0.0%N/A0.021% 8/14/2024 Great Point Partners LLC402,015$9.13M1.7%-1.4%2.669% 8/14/2024 Ally Bridge Group NY LLC218,614$4.96M3.0%-24.6%1.451% 8/8/2024 American Century Companies Inc.14,204$322K0.0%+27.1%0.094% 8/1/2024 Rhumbline Advisers13,231$300K0.0%N/A0.088% 7/26/2024 Bank of New York Mellon Corp32,579$740K0.0%N/A0.216% 5/29/2024 Opaleye Management Inc.435,573$12.79M2.8%-89.1%2.892% 5/20/2024 Virtu Financial LLC10,410$306K0.0%N/A0.069% 5/17/2024 Ikarian Capital LLC105,175$3.09M0.3%N/A0.698% 5/16/2024 Kingdon Capital Management L.L.C.497,000$14.59M1.6%-86.0%3.300% 5/14/2024 Qiming U.S. Ventures Management LLC928,964$27.27M30.4%-89.1%6.168% 5/14/2024 StemPoint Capital LP129,211$3.79M1.0%N/A0.858% 5/10/2024 Vanguard Group Inc.612,745$17.99M0.0%-85.0%4.069% 5/8/2024 Russell Investments Group Ltd.79,811$2.34M0.0%N/A0.530% 5/7/2024 Concurrent Investment Advisors LLC20,409$599K0.0%N/A0.136% 5/3/2024 Carlyle Group Inc.1,066,189$31.30M2.0%-87.8%7.080% 3/18/2024 Kingdon Capital Management L.L.C.3,540,000$2.79M0.3%+16.4%31.720% 2/15/2024 Opaleye Management Inc.3,985,340$3.14M0.8%N/A35.717% 2/7/2024 Ieq Capital LLC54,500$43K0.0%N/A0.488% 2/7/2024 Monaco Asset Management SAM249,563$197K0.1%N/A2.236% 2/5/2024Fernwood Investment Management LLC494,706$390K0.1%+8.8%4.433% Small Washington, DC Group Could Crash US Stocks (Ad)New Amazon Crisis Could Tank U.S. Stock Market A new panic is halting AI projects at Amazon and could split the entire U.S. market in two on or before Sept 30, causing a crisis "many times worse than 2008."Click here for full details while you still have time to move your money.11/13/2023 Mariner LLC652,749$457K0.0%-8.7%0.589% 11/9/2023Cowen AND Company LLC200,393$140K0.0%N/A0.181% 11/8/2023 Forefront Analytics LLC110,792$78K0.0%+59.7%0.100% 10/30/2023 Summit Trail Advisors LLC65,000$46K0.0%N/A0.059% 8/15/2023 Sphera Funds Management LTD.4,274,008$5.86M0.9%+5.7%3.874% 8/14/2023Jefferies Financial Group Inc.489,884$671K0.0%N/A0.444% 6/1/2023 Prelude Capital Management LLC54,500$99K0.0%N/A0.049% 5/16/2023 Ally Bridge Group NY LLC2,517,232$4.56M6.0%N/A2.301% 5/16/2023 BVF Inc. IL9,900,000$17.92M0.7%N/A9.051% 5/15/2023 Affinity Asset Advisors LLC476,948$863K0.3%N/A0.436% (Data available from 1/1/2016 forward) JSPR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of JSPR shares? During the previous two years, 65 institutional investors and hedge funds held shares of Jasper Therapeutics. The most heavily invested institutionals were Soleus Capital Management L.P. ($31.95M), Carlyle Group Inc. ($31.30M), Qiming U.S. Ventures Management LLC ($27.27M), Vanguard Group Inc. ($17.99M), Braidwell LP ($15.28M), Integral Health Asset Management LLC ($13.90M), and Opaleye Management Inc. ($12.79M).Learn more on Jasper Therapeutics' institutional investors. What percentage of Jasper Therapeutics' stock is owned by institutional investors? 79.85% of Jasper Therapeutics' stock is owned by institutional investors. Learn more on JSPR's institutional investor holdings. Which institutional investors have been buying Jasper Therapeutics' stock? Of the 53 institutional investors that purchased Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Opaleye Management Inc. ($3.99M), Braidwell LP ($714.66K), T. Rowe Price Investment Management Inc. ($702.76K), Kingdon Capital Management L.L.C. ($543K), Boxer Capital Management LLC ($350K), Integral Health Asset Management LLC ($300K), and StemPoint Capital LP ($264.46K). How much institutional buying is happening at Jasper Therapeutics? Institutional investors have bought a total of 3,708,808 shares in the last 24 months. This purchase volume represents approximately $56.35M in transactions. Which of Jasper Therapeutics' major shareholders have been selling company stock? Of the 14 institutional investors that sold Jasper Therapeutics' stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Ally Bridge Group NY LLC ($277.04K), Woodline Partners LP ($249.43K), Geode Capital Management LLC ($134.89K), Franklin Resources Inc. ($118.90K), Bank of America Corp DE ($105.91K), Great Point Partners LLC ($79.64K), and Ikarian Capital LLC ($50K). How much institutional selling is happening at Jasper Therapeutics? Institutional investors have sold a total of 1,070,323 shares in the last 24 months. This volume of shares sold represents approximately $18.54M in transactions. Related Companies Caribou Biosciences Major Shareholders C4 Therapeutics Major Shareholders Tevogen Bio Major Shareholders SELLAS Life Sciences Group Major Shareholders Enanta Pharmaceuticals Major Shareholders Lifevantage Major Shareholders Actuate Therapeutics Major Shareholders Nkarta Major Shareholders Nuvectis Pharma Major Shareholders Cybin Major Shareholders This page (NASDAQ:JSPR) was last updated on 8/28/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredAltucher: It Looks Like My Trump prediction is coming trueNew Hampshire just launched a Strategic Crypto Reserve — and James Altucher says it’s the first sign that “Tru...Paradigm Press | SponsoredTrump's "Big Beautiful Bill" hides ugly truthWashington’s new “Big Beautiful Bill” promises tax breaks… but the fine print tells a different story: trillio...Defi Master | SponsoredTrump’s national nightmare is hereAI is no longer just about chatbots — it’s becoming the backbone of the global economy. While U.S. firms push ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Jasper Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Jasper Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access